NCT00370318View on ClinicalTrials.gov

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

April 30, 2007

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

10 valent pneumococcal conjugate vaccine

BIOLOGICAL

Infanrix Hexa

BIOLOGICAL

Rotarix

DRUG

Paracetamol

Trial Locations (10)

628 00

GSK Investigational Site, Brno

500 01

GSK Investigational Site, Hradec Králové

377 01

GSK Investigational Site, Jindřichův Hradec

547 01

GSK Investigational Site, Náchod

728 92

GSK Investigational Site, Ostrava

532 03

GSK Investigational Site, Pardubice

150 00

GSK Investigational Site, Prague

160 00

GSK Investigational Site, Prague

190 00

GSK Investigational Site, Prague

669 00

GSK Investigational Site, Znojmo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY